| UNITED STATES |
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
| Notice of Effectiveness |
| Effectiveness Date: |
January 27,
2026 |
| Accession Number: |
0001213900-26-007469 |
| Submission Type: |
POS AM |
| CIK: |
0001841330 |
| Company Name: |
Pasithea Therapeutics Corp. |
| File Number: |
333-271010 |
|
